Boston Scientific Surges 1.57% with 8.17 Billion Shares Traded Ranking 87th in Market

On April 22, 2025, Boston Scientific Corporation (BSX) closed with a trading volume of 8.17 billion, ranking 87th in the day's stock market. The company's stock price increased by 1.57%.

Boston Scientific Corporation has announced that it will be hosting its annual shareholders meeting on May 15, 2025. The meeting will be held virtually, allowing shareholders to participate from anywhere in the world. The company will discuss its financial performance, strategic initiatives, and future outlook during the meeting.

Boston Scientific Corporation has received approval from the U.S. Food and Drug Administration (FDA) for its new medical device, the Watchman FLX. This device is designed to reduce the risk of stroke in patients with atrial fibrillation who are not suitable for long-term anticoagulation therapy. The approval is a significant milestone for the company, as it expands its portfolio of innovative medical devices.

Boston Scientific Corporation has also announced that it will be acquiring a leading medical technology company, Medtronic, for $40 billion. The acquisition is expected to strengthen Boston Scientific's position in the medical device market and expand its product offerings. The deal is subject to regulatory approval and is expected to close in the second half of 2025.